Sex differences in clinical manifestations, functional outcome, and prognostic risk factors in ischemic atherosclerotic stroke: a multicenter observational study

Bulletin of Faculty of Physical Therapy · Springer Nature · 2026-11-17 · DOI: 10.1186/s13293-026-01021-5

Аннотация

Background Biological sex is increasingly recognized as a factor influencing infarct topography, inflammatory responses, and clinical outcomes in ischemic atherosclerotic stroke (IAS). This study investigated sex-specific differences in infarct locations, systemic immune-inflammatory profiles, functional outcomes, and risk factors for poor prognosis in patients with IAS. Method This multicenter observational study included 407 patients with IAS. We recorded baseline demographics, medical history, infarct locations, and immune-inflammatory biomarkers. Functional recovery was evaluated using the modified Rankin Scale (mRS) during the subacute phase. We also tracked the 1-year incidence of major adverse cardiovascular and cerebrovascular events (MACCE). Regression models were used to identify independent predictors of poor outcomes. Results Men exhibited a higher proportion of IAS (67.6% vs. 32.4%) and significantly elevated systemic inflammatory markers, including monocyte, erythrocyte, and leukocyte counts, as well as a higher systemic inflammatory response index (SIRI, p = 0.001). Conversely, women experienced modestly poorer functional recovery (higher mRS scores, p = 0.040), higher relative platelet counts ( p = 0.001), higher platelet-to-lymphocyte ratios (PLR, p = 0.017), and a higher frequency of right brainstem infarctions ( p = 0.028) and bilateral cerebral infarctions ( p = 0.036). In multivariable models, poorer functional outcomes were associated with SIRI in men ( p = 0.031) and PLR in women ( p = 0.049). Furthermore, the 1-year MACCE incidence in men was positively associated with higher mRS scores (OR = 1.70, p = 0.016) and inversely associated with left-sided infarction (OR = 0.28, p = 0.017), whereas smoking emerged as a prognostic risk factor in women ( p = 0.009), though this requires further validation in larger cohorts due to the small number of female smokers. Conclusions IAS presents with distinct anatomical, immunological, and clinical profiles in men and women. While exploratory and requiring validation in larger cohorts, recognizing these sex-driven pathophysiological disparities may help inform future clinical management and secondary prevention strategies.

Читать у издателя →

Похожие статьи